Navigation Links
Golden Meditech Announces the Disposal of Convertible Note Issued by CCBC for over US$88 million
Date:8/25/2014

HONG KONG, Aug. 25, 2014 /PRNewswire/ -- Golden Meditech Holdings Limited (the "Company" or "Golden Meditech", 801.HK; 910801.TW), a leading integrated healthcare enterprise in China, announced that it has entered into an agreement to sell its 7% senior convertible note due 2017 in an aggregate principal amount of US$50 million issued on 3 October 2012 by China Cord Blood Corporation ("CCBC"), a non-wholly-owned subsidiary of the Company ("Convertible Note") to Magnum Opus International Holdings Limited ("Magnum") and Cordlife Group Limited ("CGL") for approximately US$88,090,000 (equivalent to approximately HK$682,697,500) in cash (the "Disposal"). Upon completion of the Disposal, each of Magnum and CGL will hold 50% of the Convertible Note.

Magnum is a private vehicle controlled by Mr. Kam Yuen, Chairman and Chief Executive Officer of the Company and Chairman of CCBC, and involves the CCBC management team. CGL is a cord blood banking services operator listed on the main board of the Singapore Exchange Securities Trading Limited, which currently owns approximately 10% of the issued shares of CCBC.

Following completion of the Disposal, Golden Meditech's shareholding in CCBC will remain unchanged at approximately 42.0% and will only be diluted to approximately 33.9% if both Magnum and CGL exercise their rights to convert their Convertible Note into CCBC shares and, accordingly, their respective shareholdings in CCBC would increase by approximately 9.7%.

With mainland China's healthcare sector continues to be driven by the government's healthcare reform, Golden Meditech believes the Disposal would strengthen its financial position and liquidity, enhancing its ability to fund its potential acquisitions or expansion of its existing healthcare related businesses in mainland China.

The transaction is
'/>"/>

SOURCE Golden Meditech Holdings Limited
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Golden Meditech Holdings Limited Announces 2011/ 2012 Annual Results
2. Golden Seeds Invests In DxUpClose, Disruptive Technology That Performs An Antibiotic Sensitivity Test At The Patients Bedside In Less Than An Hour
3. Golden Meditech Holdings Limited Announces Updates on Medical Devices Subsidiary Latest Development
4. Golden Meditech Announces 2012 / 2013 Interim Results
5. Blue Belt Technologies Announces Golden Jubilee National Hospital Completes Initial NavioPFS Unicondylar Knee Replacement Surgery
6. Blue Belt Technologies annonce que le Golden Jubilee National Hospital a réalisé la première opération NavioPFS darthroplastie unicondylaire du genou
7. Will Brazil, Russia, India and China Ever Become the Golden Goose of the Future for Life Science and Medical Device Companies?
8. Golden Meditech Proposes Open Offer to Eligible Shareholders to Subscribe One Offer Share for Every Two Shares Held
9. Liaison Healthcare Honored with Golden Bridge Business Innovation Awards
10. Golden Meditech Announces 2013 / 2014 Interim Results
11. The MED Group Announces Agreement with Golden Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015  The report on breast cancer therapeutics: pipeline ... drugs on the basis of the molecules which are ... inner lining of milk ducts or lobules responsible for ... tumor that can spread to other cells present in ... lobules is referred as lobular carcinoma, while the other ...
(Date:9/2/2015)... The quantum dot market report analyzes the ecosystem of the ... product includes medical devices, display, and others. The others segment ... storage, QD laser, and transistor. The application segment covers the ... The report also provides the geographic view for major regions ... Europe , Asia-Pacific (APAC), and ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 /PRNewswire/ ... dystrophy is an X-linked disease, which generally affects ... muscle degeneration and weakness. The disease is caused ... result in the lack of production of dystrophin ... in individuals. The lack of dystrophin weakens muscle ...
Breaking Medicine Technology:Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3
... (Nasdaq: ALTH ) today announced the initiation ... multi-center dose,escalation study of the Company,s targeted chemotherapeutic ... non-Hodgkin,s lymphoma (NHL). "We are pleased to ... Cagnoni, M.D., Chief Medical Officer of Allos. "RH1 ...
... Appropriate Patient Selection Criteria for Future Field ... ... Corporation (Nasdaq: DVAX ) presented yesterday a detailed,analysis of data ... for ragweed allergic rhinitis. The,data were reported yesterday at the annual ...
Cached Medicine Technology:Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 4Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting 2Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting 3
(Date:9/2/2015)... , ... September 02, 2015 , ... ... Things, announces its latest addition to its screen mirroring and extending product line ... Extended Wireless Display, which operates in local WIFI setting, the new Splashtop Wired ...
(Date:9/2/2015)... Pune (PRWEB) , ... September 02, 2015 , ... The ... USD 10.3 billion in 2015, at a CAGR of 5.2%. The global medical waste ... and geography. The treatment and disposal segment is expected to register the highest growth ...
(Date:9/2/2015)... ... September 02, 2015 , ... A UPMC and ... earned international recognition as a premier center for treatment of and research into ... internal bleeding and stroke. , Cure HHT, previously known as The HHT ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... Center at Children's Healthcare of Atlanta to help support childhood cancer research. ... the upcoming WSB Radio Care-A-Thon , which is the fund-raising event DoMyOwnPestControl.com ...
(Date:9/2/2015)... WI (PRWEB) , ... September 02, 2015 , ... ... Cypress Benefit Administrators is taking action after seeing a significant increase ... TPA’s Argus Claim Review division has found many cases of OON ASCs encouraging ...
Breaking Medicine News(10 mins):Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 2Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 3Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 4Health News:Medical Waste Management Market Growing at 5.2% CAGR to 2020 5Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 2Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 3Health News:UPMC-University of Pittsburgh Named Center of Excellence for Rare Disorder 4Health News:DoMyOwnPestControl.com Goes Gold for Childhood Cancer Awareness Month 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 2Health News:TPA Cracks Down on Forbidden Tactics Used by Out-of-Network Surgical Centers 3
... Inc. (Phyhealth) (Pink Sheets: PHYH), a developer of,health ... the signing of a $250,000 Note with The ... working capital to support,its general corporate regulatory and ... an additional $3,500,000 in cash, which is,designated for ...
... Approves Entry into Clinical Trials on Schedule, ... -- China,Pharma Holdings, Inc. ("China Pharma") (OTC ... generic and branded bio-pharmaceutical,products in China, announced ... been granted approval by China,s State Food ...
... Mass., Oct. 29 Boston Scientific,Corporation (NYSE: BSX ... of the U.S. armed forces and service veterans better ... Care Act of 2008 was included in the National ... law by the,President. The legislation, introduced by Representative Dave ...
... -, PITTSBURGH, Oct. 29 Mylan Inc. (NYSE: ... India-based,subsidiary in which it holds a 71.5% controlling interest, ... mg and 200 mg, with the,filing of its Abbreviated ... against Matrix within the 45-day time period provided by ...
... Irvine Pharmaceutical Services,Inc., announced today that as part ... future industry demands, the company has promoted Aryo,Nikopour to ... its staff Chief Operating Officer Greg McParland. These changes ... it gears up to launch its new,subsidiary, Avrio Biopharmaceuticals, ...
... Products, According ... from HealthLeaders-InterStudy, NASHVILLE, Tenn., Oct. 29 HealthLeaders-InterStudy, ... despite,its trend-setter reputation, California is behind the curve in ... as,insurers search for the right price for their products. ...
Cached Medicine News:Health News:Phyhealth Completes $250,000 Funding 2Health News:China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination 2Health News:China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination 3Health News:Boston Scientific Welcomes Passage of Federal Pain Care Legislation to Benefit Military Members and Veterans 2Health News:Boston Scientific Welcomes Passage of Federal Pain Care Legislation to Benefit Military Members and Veterans 3Health News:Boston Scientific Welcomes Passage of Federal Pain Care Legislation to Benefit Military Members and Veterans 4Health News:Mylan's Matrix First-to-File on Generic Version of Vfend(R) Antifungal 2Health News:Irvine Pharmaceutical Services Enhances Staff, Prepares for Innovative Expansion 2Health News:California Insurers are Behind the Curve with Consumer-Driven Health Plans 2
Full Handle Laseredge Implant Blade Knife, 5.2 mm round tip. Blade dimension: 16.5 mm x 5.2 mm x 3.8 mm x 2.4 mm....
Full Handle Laseredge Implant Blade Knife, 5.2 mm angled bevel up. Blade dimension: 16.5 mm x 5.2 mm x 4.2 mm x 1.6 mm....
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Medicine Products: